EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

American Journal of Transplantation

ISSN 1600-6135 · Elsevier BV

Latest articles

  1. Myeloid-avid mammalian target of rapamycin-inhibiting nanobiologic attenuates allograft fibrosis after lung transplantation

    Katsutaka Mineura, Charles R. Liu, Junedh M. Amrute, Shinichi Kawana, Fatima H. Elmenshawy, Jonathan L. Perez, Will Lounsbery-Scaife, Nikita Poddar, Venkatrao Nunna, Wenjun Li, Yuriko Terada, Austin Meadows, Gyu Seong Heo, William Wang, Maria Giulia Davighi, Judit Morla-Folch, Seokchan Park, Gabriel Laghlali, Eleanor Burgess, Michael Schotsaert, Yongjian Liu, Kory J. Lavine, Jon H. Ritter, Vibha N. Lama, Steven L. Brody, Ruben G. Nava, Andrew E. Gelman, Alexander S. Krupnick, Leticia Perez-Rodriguez, Dan Hasson, Abraham J.P. Teunissen, Jordi Ochando, Daniel Kreisel

    Published: 2026-11DOI: 10.1016/j.ajt.2026.05.2303

  2. Discovery of endothelial cell antibodies associated with pediatric and adult kidney allograft rejection and assessment of a non-human leukocyte antigen antibody assay

    Carrie L. Butler, Michelle J. Hickey, Meghan H. Pearl, Ying Zheng, David Gjertson, Gemalene Sunga, Lucia Chen, Sitaram Vangala, David Elashoff, Patricia Weng, Erik Lum, Suphamai Bunnapradist, Basmah Abdalla, Phuong-Thu Pham, Julie M. Yabu, Supreet Sethi, Elizabeth Kendrick, Gabriel Danovitch, Nima Nassiri, Jeffrey Veale, Hans A. Gritsch, Tiffany Bratton, Bryan Ray, Elaine F. Reed

    Published: 2026-11DOI: 10.1016/j.ajt.2026.05.2304

Volumes

2026 · 2,7742025 · 3,1332024 · 3282023 · 2952022 · 4602021 · 5782020 · 5602019 · 4812018 · 4802017 · 4872016 · 5092015 · 4832014 · 4732013 · 5622012 · 5102011 · 4622010 · 4362009 · 4392008 · 4402007 · 4272006 · 4552005 · 4702004 · 3882003 · 2962002 · 1902001 · 93

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.